• Stapled Peptides: Targeting the “Undruggable”

    Bio-IT World | SINGAPORE—Sir David Lane kicked off the 2013 Bio-IT World Asia conference this week by describing an alternative paradigm for drug discovery and development: using stapled peptides to target protein-protein interactions.

    May 30, 2013

  • Amazon Releases API for Google, Facebook Sign-In

    Computerworld | Amazon Web Services is integrating its login process with Amazon.com, Facebook and Google. Amazon calls the concept web identity federation, and released a new AWS Security Token Service (STS) API to simplify the development process.

    May 30, 2013

  • Researchers Characterize Chemical Structure of HIV Capsid

    Bio-IT World | Today researchers at the University of Illinois at Urbana- Champaign have announced the discovery of the chemical structure of the capsid for the HIV virus. The discovery was facilitated by the Blue Waters supercomputer system at the National Center for Supercomputing Applications (NCSA), and is published this week in Nature.

    May 28, 2013

  • Valeant Pharma Buys Bausch & Lomb

    New York Times Dealbook | Valeant Pharmaceuticals International of Canada has purchased Bausch & Lomb, the eye care company, for about $8.7 billion.

    May 27, 2013

  • Transforming Your Business Defined

    Bio-IT World | Guest Commentary | Transform your business before it’s transformed for you. These words convey a hard truth about modern business—external forces are rapidly conspiring to unravel even the best-laid plans. From geopolitical and economic macro trends to global threats to health and the environment, business change is now maddeningly unpredictable and capricious. Absent a proactive plan to address these new business realities, some businesses are in for challenging futures.

    May 27, 2013

  • Too Much to Ignore: Anne Wojcicki’s Plan for Health Care and Big Data

    Bio-IT World | STANFORD, CA—The challenge in healthcare is to change what is—and what isn’t—a billable question, said 23andMe founder Ann Wojcicki, giving the opening keynote yesterday at the Big Data in Biomedicine conference at Stanford University. And they key will be generating so much data that we’re forced to figure it out.

    May 23, 2013

  • PatientsLikeMe Launches Open Research Platform

    InformationWeek | PatientsLikeMe has launched its Open Research Exchange and issued a call for patients, an initiative funded by a Robert Wood Johnson Foundation grant announced earlier this year.

    May 23, 2013

  • US the Least Risky Spot for Your Data Center

    Computerworld | An survey of 30 countries finds the US to be the least risky place to open a data center, followed by the UK, Germany and Sweden. The most risky spots were Indonesia, India, and Brazil.

    May 23, 2013

  • CPT Code Concerns Raise Issues for Diagnostics Industry

    Bio-IT World | With the plummeting cost of next-generation sequencing (NGS) expanding the range of clinical genomics tests being offered by diagnostics companies and medical centers, a looming problem lies in reimbursement.

    May 21, 2013

  • The Gene Test Question

    New York Times | Angelina Jolie announced drastic action this week--a preventive double mastectomy after learning that she carries a faulty copy of BRCA1. But this type of action isn't available to all women, thanks to the high costs of gene tests.

    May 21, 2013

  • Speed in the Consumer Cloud

    ReadWrite Cloud | ReadWrite tests the speed of the top file-transfer/file-storage/file-backup services: Dropbox, Google Drive, Amazon Cloud, and Microsoft’s SkyDrive.

    May 20, 2013

  • Big R&D Spenders: Pharma and Chips

    In the Pipeline | Derek Lowe breaks down how much various companies and sectors spend on R&D. The big spenders? Drug discovery and semiconductor companies.

    May 20, 2013

  • The Elusive Exascale

    HPC Wire | Horst Simon believes we won’t be achieving exascale computing any time soon.

    May 17, 2013

  • BMS Set to Win on Cancer Combinations

    Forbes | Bristol-Myers Squibb's approved drug, Yervoy, is being tested in combination with several experimental drugs to treat advanced melanoma.

    May 16, 2013

  • Personalized Medicine's Season

    Wall Street Journal | The diagnostics market is its most attractive since 2007, and health care is the best performing sector of the public market right now.

    May 16, 2013

  • The Cost of Sequencing

    Opinionmics | If you want to talk about the cost of sequencing--how it's going down and by how much, Mick Watson has plotted it all out.

    May 15, 2013

  • Cliff Reid on Complete After BGI

    MendelsPod | Complete Genomics CEO, Cliff Reid, talks about the future after BGI’s buyout.

    May 15, 2013

  • Small Data Finding Could Help Big Data Quality

    Bio-IT World Guest Commentary | I get to have the most fun when someone wants to collaborate on a crazy idea. But crazy ideas come with unexpected challenges, too. Our paper on how dispensing methods affect datasets was published in PLOS ONE a week ago, and we would not have predicted the polarizing effect it has had.

    May 15, 2013

  • Big Data for Personalized Health

    Boston.com | GNS Healthcare's Colin Hill has been around for a while. But now is time for big data in personalized medicine, he says.

    May 13, 2013

  • Researchers Find 10% of Heart Disease Due to Spontaneous Mutations

    Yale News | Yale researchers scanned the genomes of 1800 individuals and found that 10% of congenital heart disease is due to de novo mutations, not found in affected newborn's parents.

    May 13, 2013